Claritev Corporation (CTEV) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Claritev Corporation (CTEV) Healthcare & Pipeline Overview

Claritev Corporation delivers data analytics and cost management solutions to the healthcare industry, leveraging technology to reduce medical costs and improve payment accuracy. With a focus on data-driven insights and network-based services, Claritev serves national and regional insurance companies, aiming to optimize benefit plan designs and clinical outcomes.

What Is the Investment Thesis for CTEV?

Claritev Corporation operates in the growing healthcare cost containment market. With a market capitalization of $626M, the company's analytics-based services offer potential for growth as healthcare providers and insurers seek to reduce costs and improve efficiency. The company's gross margin of 61.1% indicates a strong ability to generate profit from its services. Key value drivers include the increasing demand for data-driven cost management solutions in healthcare and the company's ability to expand its customer base. A potential risk is the company's negative profit margin of -29.3%, which needs to be addressed for long-term sustainability. The beta of 0.54 suggests lower volatility compared to the overall market.

Based on FMP financials and quantitative analysis

CTEV Key Highlights

Market Cap of $626M reflects the company's current valuation in the healthcare information services sector.

• Gross Margin of 61.1% indicates strong profitability from core services, suggesting efficient cost management.
• Profit Margin of -29.3% highlights a need for improved cost control and revenue generation strategies.
• Beta of 0.54 suggests lower volatility compared to the market, potentially appealing to risk-averse investors.
• Services cater to national and regional insurance companies, providing a stable and recurring revenue stream.

Who Are CTEV's Competitors?

CTEV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are CTEV's Key Strengths?

Strong expertise in data analytics and cost management.

• Established relationships with major insurance companies.
• Comprehensive suite of services covering payment and revenue integrity.
• Technology-enabled solutions for efficient claims processing.

What Are CTEV's Weaknesses?

Negative profit margin (-29.3%) indicates financial challenges.

• Reliance on the healthcare industry makes it susceptible to regulatory changes.
• Limited geographic diversification.
• Dependence on data accuracy and security.

What Could Drive CTEV Stock Higher?

Expansion of data and decision science services to drive revenue growth.

• Strategic partnerships with healthcare providers to enhance service offerings.
• Potential acquisitions of complementary businesses to expand market share.
• Development of new technology solutions using AI and machine learning.
• Continued focus on improving cost management and payment integrity for clients.

What Are the Key Risks for CTEV?

Financial-distress signal — its Altman Z-Score of -0.42 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
• Negative profit margin (-29.3%) poses a risk to financial sustainability.
• Changes in healthcare regulations and reimbursement policies could impact revenue.
• Data security breaches and privacy concerns could damage reputation and incur costs.
• Increasing competition from other healthcare information service providers.
• Economic downturn affecting healthcare spending could reduce demand for services.

What Are the Growth Opportunities for CTEV?

• Expansion of Data and Decision Science Services: Claritev can expand its data and decision science services to offer more sophisticated analytics solutions. The market for healthcare analytics is projected to reach $45 billion by 2028, driven by the need for better insights into patient outcomes and cost management. By leveraging its existing data assets and expertise, Claritev can develop predictive and prescriptive analytics tools that drive optimized benefit plan design and improve clinical outcomes. Timeline: Ongoing.
• Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with healthcare providers can enhance Claritev's service offerings and expand its market reach. Collaborating with providers allows Claritev to integrate its solutions directly into clinical workflows, improving the accuracy and efficiency of cost management processes. These partnerships can also provide access to valuable data and insights, further enhancing the company's analytics capabilities. Timeline: Ongoing.
• Geographic Expansion: Claritev can expand its services to new geographic markets, both domestically and internationally. The demand for healthcare cost management solutions is global, and Claritev's expertise can be applied to address similar challenges in other countries. By targeting regions with high healthcare costs and complex regulatory environments, Claritev can tap into new revenue streams and diversify its customer base. Timeline: Upcoming.
• Development of New Technology Solutions: Investing in the development of new technology solutions can differentiate Claritev from its competitors and enhance its value proposition. This includes exploring AI and machine learning technologies to automate and improve the accuracy of claims processing and cost management. By staying at the forefront of technological innovation, Claritev can attract new customers and retain existing ones. Timeline: Ongoing.
• Acquisition of Complementary Businesses: Claritev can pursue strategic acquisitions of complementary businesses to expand its service offerings and market share. Acquiring companies with expertise in areas such as healthcare IT, data analytics, or payment processing can enhance Claritev's capabilities and create synergies that drive growth. This strategy can also provide access to new customers and markets. Timeline: Upcoming.

What Are CTEV's Competitive Advantages?

• Proprietary data analytics algorithms for cost management.
• Established network of healthcare providers offering contracted discounts.
• Expertise in payment and revenue integrity services.
• Long-standing relationships with national and regional insurance companies.

What Does CTEV Do?

Founded in 1980 and formerly known as MultiPlan Corporation until its rebranding in February 2025, Claritev Corporation provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company's core offerings revolve around reducing medical costs through advanced data analytics, identifying claims over-charges, and negotiating reimbursements. Claritev also provides network-based services, offering contracted discounts with healthcare providers and outsourced network development and management. Its payment and revenue integrity services focus on identifying and removing improper charges, while also working to restore underpaid premium dollars. Additionally, Claritev offers data and decision science services, using modern data science methods to produce descriptive, predictive, and prescriptive analytics. These analytics drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care. The company serves a diverse clientele, including national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other entities involved in claim adjudication. Headquartered in New York, Claritev Corporation continues to evolve its solutions to meet the changing needs of the healthcare industry.

What Products and Services Does CTEV Offer?

• Provides data analytics solutions for healthcare cost management.
• Offers technology-enabled payment and revenue integrity services.
• Reduces medical costs through data-driven algorithms and insights.
• Detects claims over-charges and negotiates reimbursement.
• Provides contracted discounts with healthcare providers.
• Offers outsourced network development and management services.
• Identifies and removes improper and unnecessary charges paid during the claim.
• Restores and preserves underpaid premium dollars.

How Does CTEV Make Money?

• Generates revenue through analytics-based services that reduce medical costs.
• Provides network-based services offering contracted discounts with healthcare providers.
• Offers payment and revenue integrity services to identify and remove improper charges.
• Provides data and decision science services for optimized benefit plan design.

What Industry Does CTEV Operate In?

Claritev Corporation operates within the healthcare information services industry, which is experiencing growth due to increasing pressure to manage healthcare costs and improve outcomes. The industry is characterized by the adoption of data analytics and technology-enabled solutions to streamline processes and reduce inefficiencies. Claritev competes with other companies offering similar cost management and payment integrity services. The company's focus on data-driven insights and comprehensive solutions positions it to capitalize on the growing demand for healthcare cost containment strategies.

Who Are CTEV's Key Customers?

• National and regional insurance companies
• Blue Cross and Blue Shield plans
• Provider-sponsored and independent health plans
• TPAs (Third Party Administrators)
• Self-insured health plans

Company Profile

Claritev Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in McLean, US. The company is led by CEO Travis S. Dalton. CTEV has traded publicly since 2020.

Claritev Corporation Financial Trajectory

Claritev Corporation (CTEV) reported $257.5M in revenue for Q2 FY2026, reflecting 5.2% growth compared to the prior quarter. The company recorded a net loss of $59.2M, with diluted EPS of $-3.49. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, CTEV averaged $-4.26 in diluted EPS.

How Claritev Corporation Is Valued

Claritev Corporation carries a market capitalization of $626M, placing it in the small-cap category. Analyst price targets span from $40.00 to $73.00, with a consensus of $52.00. At the current price of $36.74, that implies approximately 42% upside potential. Relative to its peer group, CTEV's quantitative score of 21/100 is below the peer average of 70/100.

Return on assets is 1.1%, showing how much profit it generates from its asset base. CTEV trades at a trailing price-to-earnings ratio of 4.99, below the Healthcare sector average of ~21.50x. A current ratio of 1.28 indicates the company holds enough short-term assets to cover its near-term obligations.

Claritev Corporation's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.42 places it in the distress zone, a signal of elevated financial risk.

Claritev Corporation has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 203.0% below estimates on average.

Over the past six months, Claritev Corporation insiders filed 21 SEC Form 4 transactions — 4 sales and 17 purchases. On net that is roughly 79K shares acquired (about $278K) — insiders putting money in tends to read as conviction.

CTEV Financials

CTEV Latest News

CTEV Analyst Consensus

CTEV MoonshotScore

CTEV Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources